Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
Go back to Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026| Dominion Resources (NYSE: D) | Delayed: 63.58 -0.71 (1.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.29 | 52 Week High | $78.97 | |||
| Open | $64.01 | 52 Week Low | $64.54 | |||
| Day High | $64.20 | P/E | 52.98 | |||
| Day Low | $63.45 | EPS | $1.20 | |||
| Volume | 9,230,145 | |||||
| Ryder System (NYSE: R) | Delayed: 238.54 -0.38 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.92 | 52 Week High | $80.15 | |||
| Open | $241.42 | 52 Week Low | $45.12 | |||
| Day High | $241.42 | P/E | 51.52 | |||
| Day Low | $234.29 | EPS | $4.63 | |||
| Volume | 436,676 | |||||
